169 related articles for article (PubMed ID: 9550283)
1. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
Sternesjö J; Sandler S
Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1.
Sandler S; Sternesjö J
Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349
[TBL] [Abstract][Full Text] [Related]
3. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
Sternesjö J; Sandler S
J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
[TBL] [Abstract][Full Text] [Related]
4. Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap.
Rydgren T; Bengtsson D; Sandler S
Diabetes; 2006 May; 55(5):1407-12. PubMed ID: 16644698
[TBL] [Abstract][Full Text] [Related]
5. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
Rydgren T; Sandler S
Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1997 May; 272(21):13697-704. PubMed ID: 9153221
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
11. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function.
Welsh N; Sandler S
Mol Cell Endocrinol; 1994 Jul; 103(1-2):109-14. PubMed ID: 7958387
[TBL] [Abstract][Full Text] [Related]
12. Effects of interleukin-15 on suppression of rat pancreatic islets in vitro induced by proinflammatory cytokines.
Wallström J; Andersson AK; Sandler S
Immunol Lett; 2003 Aug; 88(2):141-5. PubMed ID: 12880684
[TBL] [Abstract][Full Text] [Related]
13. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
Sandler S; Andersson A; Hellerström C
Endocrinology; 1987 Oct; 121(4):1424-31. PubMed ID: 3308437
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
17. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
19. Intercellular differences in interleukin 1beta-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic beta-cells.
Ling Z; Chen MC; Smismans A; Pavlovic D; Schuit F; Eizirik DL; Pipeleers DG
Endocrinology; 1998 Apr; 139(4):1540-5. PubMed ID: 9528932
[TBL] [Abstract][Full Text] [Related]
20. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]